Ontology highlight
ABSTRACT:
SUBMITTER: Huber H
PROVIDER: S-EPMC5308588 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
OncoTargets and therapy 20170207
Over the last few years, dramatic changes have occurred in the treatment of chronic lymphocytic leukemia (CLL). The current standard for young and fit patients with CLL remains chemoimmunotherapy, namely the fludarabine, cyclophosphamide, and rituximab (FCR) regimen. However, novel oral therapies are presently being introduced and represent a considerable breakthrough concerning effectiveness and safety profile. In particular, the very high-risk group of CLL patients, defined by the genetic aber ...[more]